| Title: | Gout is independently associated with occult hepatic fibro-inflammation independent of obesity: a multi-cohort study using MRI-cT1 and elastography |
| Journal: | Hepatology International |
| Published: | 25 Jul 2026 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/42501272/ |
| DOI: | https://doi.org/10.1007/s12072-026-11119-y |
Publication 21364
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Background and aimsGout frequently co-occurs with steatotic liver disease, but its direct hepatotoxic effect beyond obesity remains contentious. We aimed to elucidate the independent association between gout and hepatic fibro-inflammation, particularly in subclinical cases with normal alanine aminotransferase (ALT).MethodsThis multi-cohort study integrated a UK Biobank discovery cohort (N = 21,334) using MRI iron-corrected T1 (cT1) mapping, and a multicenter clinical validation cohort (N = 512) using Transient Elastography (FibroScan) to measure liver stiffness (LSM). Multivariable regression and causal mediation analyses dissected "obesity-dependent" versus "independent" pathways.ResultsGout patients exhibited significantly elevated liver fibro-inflammation and steatosis across both cohorts. After full adjustment for metabolic confounders, gout was independently associated with liver injury in the UK Biobank (β-cT1 = 6.41 ms, p = 0.025) and clinical cohort (β-LSM = 1.21 kPa, p < 0.001). This association consistently persisted in non-obese patients with normal ALT (< 40 U/L), indicating occult injury. Mediation analysis revealed a "Double Hit" mechanism: 51.3% of the effect was obesity-mediated, while 48.7% was independent of body mass index.ConclusionGout is an independent factor associated with subclinical hepatic fibro-inflammation, even in non-obese, normo-enzymatic patients. This challenges reliance on ALT screening alone, warranting the integration of sensitive liver health assessments into routine gout management.Graphical abstract</p>
13 Authors
- Yixian Mei
- Weiqi Cai
- Qiming Huang
- Qingduo Chen
- Yongxu Lin
- Yaqing Chen
- Chenyu Xin
- Cunyu Lu
- Zheshu Chen
- Xiaoping Chen
- Jian Ding
- Qiuyuan Liu
- Dan Li
1 Application
| Application ID | Title |
|---|---|
| 912363 | The impacts of risk factors such as lifestyle, plasma metabolic markers, and genetic susceptibility on the incidence and mortality of digestive system diseases |
Enabling scientific discoveries that improve human health